Saturday, January 29, 2011

Global Biotechnology Instrumentation Market to Reach US$5.8 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

Biotechnology Instrumentation sector continues to display healthy growth supported by biotech research expansion in pharmaceutical operations, forensics, agriculture environmental monitoring, and animal husbandry sectors. Demand for faster and economical ways to produce drugs for the pharmaceutical industry, proteomics, genomics, functional genomics and combinatorial chemistry have led to the advancements of bioinstrumentation in recent years. The use of bioinstrumentation techniques has become simple and more accessible. The routine biological tests in forensic laboratories and food technology facilities are performed by instruments such as off-the-shelf kits of PCR primers, automated analytical equipment, and automated synthesizers.
Universities, particularly medical schools, are the largest end-users of biotech instruments. Product enhancements, such as automation and better reproducibility, have led to an increased demand from pharmaceutical companies. Emerging sectors in drug discovery arena such as genomics, proteomics, DNA chips, combinatorial chemistry, and high throughput screening, are fueling the demand for bioinstrumentation by the life science industry. Rapid advancements in biotechnology and pharmaceutical research require complicated analysis and purification methods. An unprecedented interest in these fields led to a significant increase in the use of analytical techniques such as HPLC, Gas Chromatography, and Mass Spectrometry.

1 comment:

  1. Biotechnology Instrumentation Market

    Biotechnology (life science and analytical) reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education.